✦ LIBER ✦

Clinical experience of bendamustine in relapsed or refractory Hodgkin lymphoma: a retrospective analysis of the French compassionate use program in 28 patients

✍ Scribed by Ghesquières, Hervé; Stamatoullas, Aspasia; Casasnovas, Olivier; Morschhauser, Franck; Gyan, Emmanuel; Gabarre, Jean; Malphettes, Marion; Clément, Laurence; Ferlay, Céline; Brice, Pauline

Book ID: 120269862
Publisher: Informa plc
Year: 2013
Tongue: English
Weight: 283 KB
Volume: 54
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428194.2013.776165

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of bendamustine in relapsed/ref

Efficacy of bendamustine in relapsed/refractory myeloma patients: results from the French compassionate use program

✍ Damaj, G.; Malard, F.; Hulin, C.; Caillot, D.; Garidi, R.; Royer, B.; Marit, G.; 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 162 KB

Bortezomib, Bendamustine, and Rituximab

Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study

✍ Fowler, N.; Kahl, B. S.; Lee, P.; Matous, J. V.; Cashen, A. F.; Jacobs, S. A.; L 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 215 KB

Equitoxicity of bolus and infusional eto

Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone)

✍ Carsten Zwick; Josef Birkmann; Norma Peter; Heinrich Bodenstein; Roland Fuchs; M 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 259 KB